WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 脳腫瘍患者における疾患状態の評価および治療後サーベイランス assessment of disease status and surveillance after treatment in patients with brain tumors
- 2. 軟髄膜転移（癌性髄膜炎）の病態、臨床的特徴、および診断 pathophysiology clinical features and diagnosis of leptomeningeal metastases carcinomatous meningitis
- 3. 肝血管腫 hepatic hemangioma
- 4. ステージIVの大腸癌患者におけるマネージメントおよび緩和のための局所療法 locoregional methods for management and palliation in patients who present with stage iv colorectal cancer
- 5. 進行性肝細胞癌に対する全身治療 systemic treatment for advanced hepatocellular carcinoma
English Journal
- Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.
- Dilly AK, Ekambaram P, Guo Y, Cai Y, Tucker SC, Fridman R, Kandouz M, Honn KV.SourceDepartment of Pathology, Wayne State University School of Medicine, Detroit, MI.
- International journal of cancer. Journal international du cancer.Int J Cancer.2013 Oct 15;133(8):1784-91. doi: 10.1002/ijc.28165. Epub 2013 Jul 13.
- Prostate cancer is the most frequently diagnosed cancer and the second leading cause of death in males in the United States. Using human prostate cancer specimens, the authors have previously shown that elevated expression levels of 12-lipoxygenase (12-LOX) occurred more frequently in advanced stage
- PMID 23526143
- Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
- Cyran CC, Fu Y, Rogut V, Chaopathomkul B, Wendland MF, Shames DM, Brasch RC.SourceCenter for Pharmaceutical and Molecular Imaging, Department of Radiology, University of California San Francisco, San Francisco, California; Department of Clinical Radiology, Laboratory for Experimental Radiology, University Hospitals Munich, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany. Electronic address: Clemens.Cyran@med.lmu.de.
- Academic radiology.Acad Radiol.2013 Oct;20(10):1256-63. doi: 10.1016/j.acra.2013.07.010.
- RATIONALE AND OBJECTIVES: To assess the applicability of a novel macromolecular polyethylene glycol (PEG)-core gadolinium contrast agent for monitoring early antiangiogenic effects of bevacizumab using dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI).MATERIALS AND METHODS: Athymic ra
- PMID 24029057
- Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.
- Zhu XD, Sun HC, Xu HX, Kong LQ, Chai ZT, Lu L, Zhang JB, Gao DM, Wang WQ, Zhang W, Zhuang PY, Wu WZ, Wang L, Tang ZY.SourceLiver Cancer Institute and Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai, 200032, People's Republic of China.
- Angiogenesis.Angiogenesis.2013 Oct;16(4):809-20. doi: 10.1007/s10456-013-9357-6. Epub 2013 May 29.
- Antiangiogenic therapy, specially sorafenib, has become the standard of care for patients with advanced hepatocellular carcinoma (HCC), however, the improvement in survival time is not satisfactory. Previous studies have found that, in some circumstances, antiangiogenic therapy promoted tumor metast
- PMID 23716000
Japanese Journal
- Antiangiogenic agent sunitinib induces epithelial to mesenchymal transition and accelerates motility of colorectal cancer cells
- The Journal of Medical Investigation 64(3.4), 250-254, 2017
- NAID 130006105181
- A Novel Clerodane Diterpene from <i>Vitex cofassus</i>
- ＣＨＥＭＩＣＡＬ ＆ ＰＨＡＲＭＡＣＥＵＴＩＣＡＬ ＢＵＬＬＥＴＩＮ 65(1), 116-120, 2017
- NAID 130005187753
- 胃がんに対する血管新生阻害薬 : ベバシズマブとラムシルマブの臨床効果の違い (特集 消化管がん(食道がん,胃がん,大腸がん等)の新しい標準的治療に対する考察)
- 腫瘍内科 = Clinical oncology 16(4), 322-326, 2015-10
- NAID 40020629072
Related Links
- Antiangiogenic agents Wayne D Klohs a, James M Hamby b a Department of Drug Development, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, MI 48105, USA b Department of ...
- Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study1 George J. Brewer, Robert D. Dick, ...
Related Pictures
★リンクテーブル★
| リンク元 | 「血管新生抑制薬」「angiogenic inhibitor」「抗血管新生薬」「anti-angiogenic agent」「angiogenesis inhibitor」 |
| 関連記事 | 「agent」「antiangiogenic」「age」 |
「血管新生抑制薬」
- 英
- angiogenesis inhibitor、antiangiogenic agent、angiogenic inhibitor
- 関
- 血管新生阻害剤、血管新生阻害物質、血管新生抑制因子、血管新生抑制剤、血管新生阻害薬、抗血管新生薬
「angiogenic inhibitor」
「抗血管新生薬」
「anti-angiogenic agent」
「angiogenesis inhibitor」
「agent」
- n.
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
「antiangiogenic」
- 血管新生抑制の、血管新生阻害の、抗血管新生の
「age」
- n.
- 年齢、歳
- v.
- 加齢する、熟成する